Why Core Scientific is Back on Investors’ Radar

Core Scientific (CORZ) has been drawing closer scrutiny after recent share price swings, with the stock showing a 1.8% decline over the past day but gains over the past week and month.

For readers tracking shorter term moves, the company’s shares have a 7% return over the past week, about 24% over the past month, and roughly 10.8% over the past 3 months, with a year to date return near 30%.

The recent 7% one week and 23.5% one month share price returns, together with a 176.4% one year total shareholder return at a share price of $20.81, show how momentum has been building as investors reassess Core Scientific’s growth potential and risk profile.

If you are looking beyond a single stock, this is a good moment to see what else is moving in digital assets infrastructure and related themes through our 23 cryptocurrency and blockchain stocks

With the shares up sharply over the past year, a recent one day pullback and a price around $20.81 that still sits below an average analyst target of about $26.36, is there still upside on the table, or is future growth already priced in?

Most Popular Narrative: 21.2% Undervalued

The most widely followed narrative puts Core Scientific’s fair value at $26.40 versus the last close of $20.81, framing the current price as a discount to modeled future earnings power.

Core Scientific secured a major HPC contract with CoreWeave, with a total revenue potential of $8.7 billion over a 12-year term, significantly boosting future revenue compared to their current levels. The company is expanding HPC infrastructure capacity by reallocating resources from Bitcoin mining, adding new sites, and extending existing ones, with the expectation that this will drive future revenue growth as data center needs rise.

Want to see what kind of growth, margins, and future earnings multiple support that fair value? The narrative emphasizes aggressive expansion and a step change in profitability. You can examine which assumptions carry the most weight.

Result: Fair Value of $26.40 (UNDERVALUED)

However, this hinges on CoreWeave contract execution and the shift away from Bitcoin mining, while recent losses and post-restructuring uncertainties could still unsettle the story.

Another Angle on Valuation

The popular fair value of $26.40 rests on long term earnings forecasts, but the current P/S of 20.6x tells a much tougher story. That is far above the US Software average of 3.7x, the peer average of 3.8x, and even the fair ratio of 5.5x, which points to clear valuation risk if expectations ease.

Before leaning too hard on any single fair value, it helps to see what the numbers say about this price through a simple multiples lens. It is also useful to consider how much sentiment would need to cool for the ratio to move closer to that fair ratio over time. See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Does the mix of optimism and concern in this story match your own view, or feel a bit stretched? Check the numbers yourself, weigh both sides, and then see how the current core thesis stacks up against 1 key reward and 2 important warning signs.

Looking for more investment ideas?

If Core Scientific has caught your attention, do not stop here. Broaden your watchlist with other focused ideas that could complement or contrast this thesis.

• Target potential bargains by scanning for companies that combine quality fundamentals with attractive prices through the 54 high quality undervalued stocks.
• Strengthen your income stream by reviewing companies with substantial payouts using the 13 dividend fortresses.
• Prioritize resilience by checking out companies with robust financial footing through the solid balance sheet and fundamentals stocks screener (42 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.